RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RGLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Regulus Therapeutics Inc. stock downgraded from Strong Buy Candidate to Buy Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Buy candidate since Mar 15, 2024 Gain 36.49% PDF

No changes to the price of Regulus Therapeutics Inc. stock on the last trading day (Thursday, 28th Mar 2024). During the last trading day the stock fluctuated 4.29% from a day low at $2.80 to a day high of $2.92. The price has risen in 7 of the last 10 days and is up by 17.79% over the past 2 weeks.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $2.90 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 92.08% during the next 3 months and, with a 90% probability hold a price between $3.22 and $5.58 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RGLS Signals & Forecast

The Regulus Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.77 and $1.89. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for Regulus Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.45 and $2.43. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Regulus Therapeutics Inc. finds support just below today's level at $2.45. If this is broken, then the next support from accumulated volume will be at $2.43 and $2.36.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.120 between high and low, or 4.29%. For the last week, the stock has had daily average volatility of 9.81%.

The Regulus Therapeutics Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $2.78 (-3.38%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 81 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (RGLS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Regulus Therapeutics Inc. to open at $2.87, and during the day (based on 14 day Average True Range), to move between $2.57 and $3.19, which gives a possible trading interval of +/-$0.306 (+/-10.64%) up or down from last closing price. If Regulus Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 21.27% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.45, some $0.435 (15.10%) from the current price of $2.88, our system finds the risk reward attractive.

Is Regulus Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Regulus Therapeutics Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 3.022 Buy Candidate Downgraded

Predicted Opening Price for Regulus Therapeutics Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.87 ( 0.463%) $2.88

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RGLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.99 3.70 %
R2 2.94 2.11 %
R1 2.91 1.13 %
Current price: 2.88
Support S1 2.82 -2.05 %
S2 2.79 -3.04 %
S3 2.75 -4.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 2.88
Support S1 2.45 -15.10%
S2 2.43 -15.63%
S3 2.36 -18.06%

FAQ

What is the symbol for Regulus Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Regulus Therapeutics Inc. is RGLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Regulus Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Regulus Therapeutics Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Regulus Therapeutics Inc. Stock?
Regulus Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regulus Therapeutics Inc. Stock.

What's the current price of Regulus Therapeutics Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Regulus Therapeutics Inc. (RGLS) share was $2.88.

What is the 52-week high and low for Regulus Therapeutics Inc. Stock?
The 52-week high for Regulus Therapeutics Inc. Stock is $3.79 and the 52-week low is $0.780.

What is the market capitalization of Regulus Therapeutics Inc. Stock?
As of the 2024-03-28, the market capitalization of Regulus Therapeutics Inc. is 188.54M.

When is the next earnings date for Regulus Therapeutics Inc.?
The upcoming earnings date for Regulus Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Regulus Therapeutics Inc.

Regulus Therapeutics. Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study... RGLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT